BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31692911)

  • 21. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.
    Eltemamy MM; Leapman MS; Cowan JE; Westphalen A; Shinohara K; Carroll PR
    J Urol; 2016 Sep; 196(3):727-33. PubMed ID: 27117443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
    Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
    J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the Time Interval from Biopsy to Radical Prostatectomy Affect the Postoperative Oncologic Outcomes in Korean Men?
    Kim SJ; Ryu JH; Yang SO; Lee JK; Jung TY; Kim YB
    J Korean Med Sci; 2019 Sep; 34(37):e234. PubMed ID: 31559708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family history and prostate cancer screening with prostate-specific antigen.
    Mäkinen T; Tammela TL; Stenman UH; Määttänen L; Rannikko S; Aro J; Juusela H; Hakama M; Auvinen A
    J Clin Oncol; 2002 Jun; 20(11):2658-63. PubMed ID: 12039927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
    Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay.
    Baden J; Adams S; Astacio T; Jones J; Markiewicz J; Painter J; Trust C; Wang Y; Green G
    J Urol; 2011 Nov; 186(5):2101-6. PubMed ID: 21944123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer.
    Nordström T; Akre O; Aly M; Grönberg H; Eklund M
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):57-63. PubMed ID: 29259293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Kim JH; Doo SW; Yang WJ; Lee KW; Lee CH; Song YS; Jeon YS; Kim ME; Kwon SS
    Int J Urol; 2014 Oct; 21(10):987-90. PubMed ID: 24825391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer.
    Costa DN; Lotan Y; Rofsky NM; Roehrborn C; Liu A; Hornberger B; Xi Y; Francis F; Pedrosa I
    J Urol; 2016 Jan; 195(1):80-7. PubMed ID: 26192254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
    Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
    Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy.
    Seisen T; Rouprêt M; Brault D; Léon P; Cancel-Tassin G; Compérat E; Renard-Penna R; Mozer P; Guechot J; Cussenot O
    Prostate; 2015 Jan; 75(1):103-11. PubMed ID: 25327361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml.
    Li YH; Elshafei A; Li J; Gong M; Susan L; Fareed K; Jones JS
    Eur Urol; 2014 Jun; 65(6):1178-83. PubMed ID: 23768632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy.
    Spurgeon SE; Mongoue-Tchokote S; Collins L; Priest R; Hsieh YC; Peters LM; Beer TM; Mori M; Garzotto M
    Urology; 2007 May; 69(5):931-5. PubMed ID: 17482937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological features of hereditary prostate cancer.
    Keetch DW; Humphrey PA; Smith DS; Stahl D; Catalona WJ
    J Urol; 1996 Jun; 155(6):1841-3. PubMed ID: 8618269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
    Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.